Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

Putin promises to punish those behind the uprising

Published

11 months ago

on

Prigozhin may have been publicly excused, but experts warn he should watch his back

The Wagner Group’s rebellion against the Kremlin shocked the world recently as it ended as quickly as it had begun.

However, it came as no surprise to U.S. intelligence agencies that had been watching the tension growing for days.

And for a moment, it looked like they would march on Moscow.

While he may have been publicly exonerated in exchange for retreating from the capital, Prigozhin is still likely a wanted man, said Keith Suter, global futurist.

“[Prigozhin] has gone into exile somewhere, but he is still obviously on the hit list for the FSB (Russian national police),” he said, “they’re going to go after him.”

Suter cited the poisoning of the former Russian military officer, Sergei Skripal and his daughter Yulia Skripal, by the FSB in Salisbury, England in 2018, as an example of the lengths the agency will go to.

Related Topics:
Continue Reading

News

Does American media have TikTok bias?

Published

2 hours ago

on

May 16, 2024

By

While the fate of TikTok remains uncertain in the U.S.—there is no shortage of possibilities.

Euro Bloch is a comprehensive program designed to highlight the breadth of topics and issues within the EU political landscape. It offers insightful analysis within the evolving framework of relations between the European Union and Australia/Asia-Pacific region. Hosted by Natanael Bloch.

Next month’s EU elections are looming, with the far-right gaining traction. In this episode, Natanael is joined by Professor Bruce Wilson, Director of EU Centre of Excellence at RMIT University. #EURO BLOCH

Continue Reading

News

Will the U.S. approve MDMA therapy?

Published

1 day ago

on

May 15, 2024

By

MDMA is a drug commonly known as molly or ecstasy.

Some medical professionals say it can be helpful for people with post-traumatic stress disorder — which is why a group has been fighting to get MDMA legalized as a prescription drug.

Currently, the U.S. Food and Drug Administration is reviewing an application to use MDMA to treat PTSD. The agency is expected to announce its ruling as soon as August.

Anna Silman, a features correspondent with Business Insider joins Veronica Dudo to discuss. #IN AMERICA TODAY #trending #drugs #MDMA #MDMATherapy #business #pharmaceutical

Continue Reading

Trending Now